Cellink AB Valuation
| CLLKF Stock | USD 1.98 0.02 1.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Cellink AB shows a prevailing Real Value of $1.78 per share. The current price of the firm is $1.98. Our model approximates the value of Cellink AB from analyzing the firm fundamentals such as Profit Margin of 0.02 %, shares outstanding of 69.07 M, and Return On Equity of 0.0068 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cellink AB's price fluctuation is very risky at this time. Calculation of the real value of Cellink AB is based on 3 months time horizon. Increasing Cellink AB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellink pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cellink AB. Since Cellink AB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellink Pink Sheet. However, Cellink AB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.98 | Real 1.78 | Hype 1.98 | Naive 1.75 |
The real value of Cellink Pink Sheet, also known as its intrinsic value, is the underlying worth of Cellink AB Company, which is reflected in its stock price. It is based on Cellink AB's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cellink AB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cellink AB helps investors to forecast how Cellink pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellink AB more accurately as focusing exclusively on Cellink AB's fundamentals will not take into account other important factors: About Cellink AB Valuation
The pink sheet valuation mechanism determines Cellink AB's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cellink AB. We calculate exposure to Cellink AB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cellink AB's related companies.BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.
8 Steps to conduct Cellink AB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cellink AB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cellink AB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cellink AB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cellink AB's revenue streams: Identify Cellink AB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cellink AB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cellink AB's growth potential: Evaluate Cellink AB's management, business model, and growth potential.
- Determine Cellink AB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cellink AB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cellink AB Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cellink AB does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 62.1 M | |
| Retained Earnings | -273.8 M |
Complementary Tools for Cellink Pink Sheet analysis
When running Cellink AB's price analysis, check to measure Cellink AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellink AB is operating at the current time. Most of Cellink AB's value examination focuses on studying past and present price action to predict the probability of Cellink AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellink AB's price. Additionally, you may evaluate how the addition of Cellink AB to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |